Ireland, a long-standing Gavi donor since 2002, strongly supports the Alliance’s mission to expand access to life-saving vaccines for children in the world’s lowest-income and most fragile countries. This commitment reflects Ireland’s broader development priorities, including reducing health inequalities, strengthening health systems and ensuring that the most vulnerable communities are not left behind.
Ireland has steadily increased its financial support to Gavi over successive replenishment cycles. It pledged €15 million (US$ 16.8 million) for the 2016–2020 strategic period, increased this to €18 million (US$ 19.8 million) for 2021–2025 and provided a total of €14 million (US$15.5 million) to the Gavi COVAX Advance Market Commitment (AMC) to support equitable access to COVID-19 vaccines. Ireland also joined other Team Europe partners in supporting the launch of the African Vaccine Manufacturing Accelerator (AVMA) in 2024 by committing €750,000 (US$ 710,000), helping to strengthen sustainable vaccine manufacturing capacity across Africa.
Most recently, at the Global Summit: Health & Prosperity through Immunisation in June 2025, Ireland pledged €21.6 million (US$ 25.6 million) for the 2026–2030 period, representing a further 20% increase in support, and reaffirming its commitment to immunisation, global health security and protecting children from vaccine-preventable diseases.
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: